Biotech News
TELA Bio Reports First Quarter 2026 Financial Results
ir.telabio.com2026-05-12 20:08 EST
MALVERN, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2026.